Narayanan NS - Search Results

1

Glycolysis-enhancing α₁-adrenergic antagonists modify cognitive symptoms related to Parkinson's disease.

Weber MA, Sivakumar K, Tabakovic EE, Oya M, Aldridge GM, Zhang Q, Simmering JE, Narayanan NS. Weber MA, et al. Among authors: narayanan ns. NPJ Parkinsons Dis. 2023 Mar 2;9(1):32. doi: 10.1038/s41531-023-00477-1. NPJ Parkinsons Dis. 2023. PMID: 36864060 Free PMC article.

2

Disease-modifying therapeutic directions for Lewy-Body dementias.

Zhang Q, Kim YC, Narayanan NS. Zhang Q, et al. Among authors: narayanan ns. Front Neurosci. 2015 Aug 20;9:293. doi: 10.3389/fnins.2015.00293. eCollection 2015. Front Neurosci. 2015. PMID: 26347604 Free PMC article. Review.

3

Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease.

De Jesús-Cortés H, Miller AD, Britt JK, DeMarco AJ, De Jesús-Cortés M, Stuebing E, Naidoo J, Vázquez-Rosa E, Morlock L, Williams NS, Ready JM, Narayanan NS, Pieper AA. De Jesús-Cortés H, et al. Among authors: narayanan ns. NPJ Parkinsons Dis. 2015;1:15010-. doi: 10.1038/npjparkd.2015.10. Epub 2015 May 21. NPJ Parkinsons Dis. 2015. PMID: 27158662 Free PMC article.

4

Parkinson's Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles.

Aldridge GM, Birnschein A, Denburg NL, Narayanan NS. Aldridge GM, et al. Among authors: narayanan ns. Front Neurol. 2018 Mar 12;9:123. doi: 10.3389/fneur.2018.00123. eCollection 2018. Front Neurol. 2018. PMID: 29593630 Free PMC article.

5

Scopolamine and Medial Frontal Stimulus-Processing during Interval Timing.

Zhang Q, Jung D, Larson T, Kim Y, Narayanan NS. Zhang Q, et al. Among authors: narayanan ns. Neuroscience. 2019 Aug 21;414:219-227. doi: 10.1016/j.neuroscience.2019.07.004. Epub 2019 Jul 9. Neuroscience. 2019. PMID: 31299344 Free PMC article.

6

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.

Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, Gao L, Ji X, Welsh MJ, Liu L. Cai R, et al. Among authors: narayanan ns. J Clin Invest. 2019 Oct 1;129(10):4539-4549. doi: 10.1172/JCI129987. J Clin Invest. 2019. PMID: 31524631 Free PMC article.

7

Coronavirus Disease 2019 Case Fatality and Parkinson's Disease.

Zhang Q, Schultz JL, Aldridge GM, Simmering JE, Narayanan NS. Zhang Q, et al. Among authors: narayanan ns. Mov Disord. 2020 Nov;35(11):1914-1915. doi: 10.1002/mds.28325. Epub 2020 Oct 15. Mov Disord. 2020. PMID: 32954522 Free PMC article. No abstract available.

8

Approach to Cognitive Impairment in Parkinson's Disease.

Zhang Q, Aldridge GM, Narayanan NS, Anderson SW, Uc EY. Zhang Q, et al. Among authors: narayanan ns. Neurotherapeutics. 2020 Oct;17(4):1495-1510. doi: 10.1007/s13311-020-00963-x. Epub 2020 Nov 17. Neurotherapeutics. 2020. PMID: 33205381 Free PMC article. Review.

9

Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.

Simmering JE, Welsh MJ, Liu L, Narayanan NS, Pottegård A. Simmering JE, et al. Among authors: narayanan ns. JAMA Neurol. 2021 Apr 1;78(4):407-413. doi: 10.1001/jamaneurol.2020.5157. JAMA Neurol. 2021. PMID: 33523098 Free PMC article.

10

Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson's disease.

Singh A, Cole RC, Espinoza AI, Evans A, Cao S, Cavanagh JF, Narayanan NS. Singh A, et al. Among authors: narayanan ns. NPJ Parkinsons Dis. 2021 Feb 15;7(1):14. doi: 10.1038/s41531-021-00158-x. NPJ Parkinsons Dis. 2021. PMID: 33589640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page